Random

Opioid News

Long-Term ADHD Stimulant Use Linked to Opioid Use

Long-Term ADHD Stimulant Use Linked to Opioid Use

A New Opioid Deterrent Falls Short For FDA

A New Opioid Deterrent Falls Short For FDA

Suzanne B. Robotti

The Price of Fighting Opioid Addiction With Drugs

The Price of Fighting Opioid Addiction With Drugs

Pain Docs Warn Against Opioids

Pain Docs Warn Against Opioids

Suzanne B. Robotti

Prenatal Opioid Exposure Can Harm Children And Teens

Prenatal Opioid Exposure Can Harm Children And Teens

Suzanne B. Robotti

Overprescribing Opioids for Cancer Survivors

Overprescribing Opioids for Cancer Survivors

Opioid-Related Complications Sending More Seniors to Hospital

Opioid-Related Complications Sending More Seniors to Hospital

Opioid Prescribing Declining

Quick Hits: Opioid Prescribing Declining & More

Black Market Sales of Opioid Prescription Drugs Online Increased

Sales of Black Market Opioid Prescription Drugs Soar

FDA Requiring Long-Term Research of OxyContin Use

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti

hallucinations tamiflu

Should Kids Be Given Codeine?

DOJ Going After Drug Makers In Opioid Epidemic Fight

DOJ Going After Drug Makers In Opioid Epidemic Fight

News Opioid News Quick Hits

Quick Hits: Abuse-Deterrent Opioids Don’t Deter & More

Opioid Prescription Painkillers Have Hidden, Deadly Side Effects

Opioid Prescription Painkillers Have Hidden Deadly Side Effects

Opioids Not Worth The Risk For Chronic Pain Sufferers

Opioids Not Worth The Risk For Chronic Pain Sufferers

New Med Doesn’t Help Back Pain

Quick Hits: New Med Doesn’t Help Back Pain, Acupuncture & More

California Bills Zero In On Risky Pain Pill Prescribers

California Bills Zero In On Risky Pain Pill Prescribers

Opioids

Opioids

The FDA Calls For Opana's Removal From The Market

The FDA Calls For Opana’s Removal From The Market

FDA Advisory Committee: Weighing Risks and Benefits of Opana ER

Weighing Risks and Benefits of Opana ER

Suzanne B. Robotti

Load More

x

x